Ustekinumab or Vedolizumab in Patient ' s With Crohn ' s Disease Ustekinumab or Vedolizumab in Patient ' s With Crohn ' s Disease

This study indicates that in patients with Crohn ' s disease refractory to anti-TNF, ustekinumab is more effective than vedolizumab as maintenance treatment.Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news